Use of trifluoroperazine isolates a [3H]ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits

Journal of Pharmacology and Experimental Therapeutics

Volumn 296, Issue 1, 2001, Pages 150-159

  Coughenour, Linda L ^a   Barr, Bridget M ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; 1,5 (DIETHYLAMINO)PIPERIDINE; 3 (2 CARBOXY 2 PHENYLETHENYL) 4,6 DICHLORO 1H INDOLE 2 CARBOXYLIC ACID; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; AGMATINE; ARCAINE; CIRAZOLINE; CLONIDINE; DIZOCILPINE; GLUTAMIC ACID; GLYCINE; IFENPRODIL; MAGNESIUM CHLORIDE; MAGNESIUM ION; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PIPERIDINE DERIVATIVE; POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMINE; TENOCYCLIDINE; TRIFLUOPERAZINE; TRITIUM; UNCLASSIFIED DRUG; VOLTAGE GATED CHANNEL FORMING PROTEIN; ZINC ION;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN MEMBRANE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; NONHUMAN; OOCYTE; PH; PRIORITY JOURNAL; RAT; XENOPUS LAEVIS;

ALLOSTERIC REGULATION; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; BRAIN; EXCITATORY AMINO ACID ANTAGONISTS; HYDROGEN-ION CONCENTRATION; MAGNESIUM; MEMBRANES; OOCYTES; PIPERIDINES; POLYAMINES; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; TRIFLUOPERAZINE; XENOPUS; ZINC;

EID: 0035193095     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. The NMDA receptor, its channel and its modulation by glycine
2. 3H]ifenprodil to NMDA receptors in rat brain
3. Ifenprodil and eliprodil: Neuroprotective NMDA receptor antagonists and calcium channel blockers
4. Ifenprodil and SL 82.0715 are antagonists at the polyamine site of the N-methyl-D-aspartate (NMDA) receptor
5. Antagonists selective for NMDA receptors containing the NR2B subunit
6. 3H](+)-3-PPP to sigma binding sites in rat brain
7. 3H]ifenprodil binding in rat brain
8. Actions of 4-phenyl-1-(4-phenybutyl)piperidine (PPBP) analogs correlated with inhibition at NR1A/NR2B NMDA receptors or sigma binding sites
9. 3H]ifenprodil binding sites in the rat brain
10. The glutamate receptor ion channels
11. Modulation of the N-methyl-D-aspartate receptor by haloperidol: NR2B-specific interactions
12. Interactions between ifenprodil and the NR2B subunit of the N-methyl-D-aspartate receptor
13. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia
14. Synthesis of N-substituted 4-(4-hydroxyphenyl)piperidines, 4-(4-hydroxybenzyl)piperidines, and (±)-3-(4-hydroxyphenyl)pyrrolidines: Selective antagonists at the 1A/2B NMDA receptor subtype
15. 3H]ifenprodil binding to sigma receptors in rat brain
16. Interactions of erythro-ifenprodil, threo-ifenprodil, erythro-iodoifenprodil, and eliprodil with subtypes of sigma receptors
17. 3H]ifenprodil binding in rat brain
18. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons
19. An allosteric interaction between the NMDA receptor polyamine and ifenprodil sites in rat cultured cortical neurones
20. 3H]dizocilpine association kinetics distinguish stimulatory and inhibitory polyamine sites of N-methyl-D-aspartate receptors
21. 3H]ifenprodil
22. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system
23. Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition
24. 3H]ifenprodil sites in the rat brain: Possible relationship to NMDAR2B receptors and calmodulin
25. Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: Interaction with polyamines
26. Neuroprotective potential of the polyamine site-directed NMDA receptor antagonists-ifenprodil and eliprodil
27. 3H]ifenprodil, a novel NMDA antagonist, to a polyamine-sensitive site in the rat cerebral cortex
28. Polyamine effects on radioligand binding to receptors and recognition sites
29. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain
30. A review of NMDA receptors and the phencyclidine model of schizophrenia
31. Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18 h) therapeutic window
32. 3H]tolyl)guanidine: A selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs
33. Subtype-selective antagonism of NMDA receptors by nylidrin
34. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: Selectivity and mechanisms at recombinant heteromeric receptors
35. Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro
36. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states
37. Subunit- and site-specific pharmacology of the NMDA receptor channel
38. NMDA receptor involvement in two animal models of Parkinson's disease
39. 4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: A novel, potent, and selective NR1/2B NMDA receptor antagonist